Jay Gelfman
Chief Operations OfficerMr. Jay Gelfman was Senior Vice President of Operations of MaxCyte, Inc. from 2024 until April 2026 and serves as Chief Operations Officer since April 2026. Mr. Gelfman’s diverse experience as a cross-functional finance, information technology and operations leader has allowed him to guide numerous organizations through successful business transformations. Previously, he was the Senior Director of Financial Planning and Analysis at MaxCyte after serving in several leadership positions of increasing responsibility at Innate Pharma, AstraZeneca, MedImmune and Accenture. Mr. Gelfman earned a Master of Business Administration in finance and information systems from the University of Maryland’s Robert H. Smith School of Business after receiving a Bachelor of Science in finance from the Smeal College of Business at Penn State University.
Positions
- Company NameMaxCyte, Inc.Stock CodeMXCTPositionChief Operations OfficerColleagues
- MMMaher MasoudPresident, CEO & Executive Director
- RHRichard Huntington DouglasIndependent Non-Executive Chairman of the Board
- PAParmeet AhujaChief Financial Officer
- AMAna-Paula Martins FernandesSenior Vice President of Global Sales
- SKSidharth KapileshwarChief Corporate Development Officer
- WWWilliam W. BrookeIndependent Non-Executive Director
- RHRekha HemrajaniIndependent Non-Executive Director
- PJPatrick J. BalthropIndependent Non-Executive Director
